
Bupropion and its photoreactive analog (±)-SADU-3-72 interact with luminal and non-luminal sites at human α4β2 nicotinic acetylcholine receptors
Keywords: Human α4β2 nicotinic acetylcholine receptor; Bupropion; (±)-SADU-3-72; Molecular docking; Luminal and non-luminal sites; Ca2+ influx; AChR; nicotinic acetylcholine receptor; NCA; noncompetitive antagonist; (±)-BP; (±)-bupropion [(±)-2-(tert-butylami